{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:17:47Z","timestamp":1787001467909,"version":"build-2736575974"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1023\/a:1018895417831","type":"journal-article","created":{"date-parts":[[2003,2,19]],"date-time":"2003-02-19T16:23:59Z","timestamp":1045671839000},"page":"447-458","source":"Crossref","is-referenced-by-count":22,"title":["Improving the Gastrointestinal Safety of NSAIDs The Development of Misoprostol-From Hypothesis to Clinical Practice"],"prefix":"10.1007","volume":"43","author":[{"given":"Fred E.","family":"Silverstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"294536_CR1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1994.03520010077036","volume":"272","author":"NIH Consensus Development Panel on Helicobacter pylori in","year":"1994","unstructured":"NIH Consensus Development Panel on Helicobacter pyloriin Peptic Ulcer Disease. Helicobacter pyloriin peptic ulcer disease. JAMA 272:65- 69, 1994","journal-title":"JAMA"},{"key":"294536_CR2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-116-9-705","volume":"116","author":"DY Graham","year":"1992","unstructured":"Graham DY, Lew GM, Klein PD, et al: Effect of treatment of Helicobacter pyloriinfection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 116:705- 708, 1992","journal-title":"Ann Intern Med"},{"key":"294536_CR3","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJM196706082762308","volume":"267","author":"HW Davenport","year":"1967","unstructured":"Davenport HW: Salicylate damage to the gastric mucosal barrier. N Engl J Med 267:1307- 1312, 1967","journal-title":"N Engl J Med"},{"key":"294536_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0016-5107(81)73165-1","volume":"27","author":"JL Smith","year":"1981","unstructured":"Smith JL, Graham DY, Dobbs SM: Time course, extent and duration of acute aspirin injury to the stomach of man. Gastrointest Endosc 27:129, 1981 (abstract)","journal-title":"Gastrointest Endosc"},{"key":"294536_CR5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/gut.22.4.283","volume":"22","author":"SJ Konturek","year":"1981","unstructured":"Konturek SJ, Obtulowicz W, Sito E, et al: Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: Effect of aspirin and paracetamol. Gut 22:283- 289, 1981","journal-title":"Gut"},{"key":"294536_CR6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJM198007173030305","volume":"303","author":"FL Lanza","year":"1980","unstructured":"Lanza FL, Royer GL, Nelson RS: Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 303:136 - 138, 1980","journal-title":"N Engl J Med"},{"key":"294536_CR7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-91-4-517","volume":"91","author":"GR Silvoso","year":"1979","unstructured":"Silvoso GR, Ivey KJ, Butt JH, et al: Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 91:517- 520, 1979","journal-title":"Ann Intern Med"},{"key":"294536_CR8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0016-5107(80)73248-0","volume":"26","author":"OO Lockard","year":"1980","unstructured":"Lockard OO, Ivey KJ, Butt JH, Silvoso GR, Sisk C, Holt S: The prevalence of duodenal lesions in patients with rheumatic disease s on chronic aspirin therapy. Gastrointest Endosc 26:5- 7, 1980","journal-title":"Gastrointest Endosc"},{"key":"294536_CR9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF01536266","volume":"34","author":"MG Robinson","year":"1989","unstructured":"Robinson MG, Griffin JW, Bowers J, et al: Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci 34:424 - 428, 1989","journal-title":"Dig Dis Sci"},{"key":"294536_CR10","first-page":"1153","volume":"82","author":"EN Larkai","year":"1987","unstructured":"Larkai EN, Smith JL, Lidsky MD, Graham DY: Gastroduode nal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 82:1153- 1158, 1987","journal-title":"Am J Gastroenterol"},{"key":"294536_CR11","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0140-6736(88)92892-9","volume":"2","author":"DY Graham","year":"1988","unstructured":"Graham DY, Agrawal NM, Roth S: Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, doubleblind, placebo-controlled trial. Lancet 2:1277- 1280, 1988","journal-title":"Lancet"},{"key":"294536_CR12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/ard.47.6.478","volume":"47","author":"D Farah","year":"1988","unstructured":"Farah D, Sturrock RD, Russell RI: Peptic ulcer in rheumatoid arthritis. Ann Rheum Dis 47:478 - 480, 1988","journal-title":"Ann Rheum Dis"},{"key":"294536_CR13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/bmj.297.6655.1017","volume":"297","author":"RSB Ehsanullah","year":"1988","unstructured":"Ehsanullah RSB, Page MD, Tildesley G, Wood JR: Prevention of gastroduodenal damage induced by nonsteroidal antiin flammatory drugs: controlled trial with ranitidine. BMJ 297:1017- 1021, 1988","journal-title":"BMJ"},{"key":"294536_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.1780380103","volume":"38","author":"DR Lichtenstein","year":"1995","unstructured":"Lichtenstein DR, Syngal S, Wolfe MM: Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract: The double-edged sword. Arthritis Rheum 38:5- 18, 1995","journal-title":"Arthritis Rheum"},{"key":"294536_CR15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.1980.03300330019023","volume":"243","author":"Aspirin Myocardial Infarction Study Research Group","year":"1980","unstructured":"Aspirin Myocardial Infarction Study Research Group: A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 243:661- 669, 1980","journal-title":"JAMA"},{"key":"294536_CR16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/gut.28.5.527","volume":"28","author":"CP Armstrong","year":"1987","unstructured":"Armstrong CP, Blower AL: Non-steroidal anti-inflammatory drugs and life threatening complication of peptic ulceration. Gut 28:527- 532, 1987","journal-title":"Gut"},{"key":"294536_CR17","first-page":"1081","volume":"83","author":"DY Graham","year":"1988","unstructured":"Graham DY, Smith JL: Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol 83:1081- 1084, 1988","journal-title":"Am J Gastroenterol"},{"key":"294536_CR18","first-page":"3","volume":"19","author":"Labeling revisions for NSAIDs","year":"1989","unstructured":"Labeling revisions for NSAIDs. FDA Drug Bull 19:3- 4, 1989","journal-title":"FDA Drug Bull"},{"key":"294536_CR19","first-page":"21","volume":"8","author":"JF Fries","year":"1991","unstructured":"Fries JF: NSAID gastropathy: Epidemiology. J Musculoskel Med 8:21- 28, 1991","journal-title":"J Musculoskel Med"},{"issue":"suppl28","key":"294536_CR20","first-page":"6","volume":"18","author":"JF Fries","year":"1991","unstructured":"Fries JF: NSAID gastropathy: The second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol 18( suppl 28):6 - 10, 1991","journal-title":"J Rheumatol"},{"key":"294536_CR21","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/art.1780281014","volume":"28","author":"HE Paulus","year":"1985","unstructured":"Paulus HE: FDA arthritis advisory committee meeting: Postmarke ting surveillance of non-steroidal anti-inflammatory drugs. Arthritis Rheum 28:1168 - 1169, 1985","journal-title":"Arthritis Rheum"},{"key":"294536_CR22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-114-4-307","volume":"114","author":"AH Soll","year":"1991","unstructured":"Soll AH, Weinstein WM, Kurata J, McCarthy D: Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 114:307- 319, 1991","journal-title":"Ann Intern Med"},{"key":"294536_CR23","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/gut.32.7.730","volume":"32","author":"J Holvoet","year":"1991","unstructured":"Holvoet J, Terriere L, Van Hee W, Verbist L, Fierens E, Hautekeete ML: Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: A case- control study. Gut 32:730 - 734, 1991","journal-title":"Gut"},{"key":"294536_CR24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","volume":"115","author":"SE Gabriel","year":"1991","unstructured":"Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: A meta-analysis. Ann Intern Med 115:787- 796, 1991","journal-title":"Ann Intern Med"},{"issue":"suppl4","key":"294536_CR25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00003495-198600324-00007","volume":"32","author":"KJ Ivey","year":"1986","unstructured":"Ivey KJ: Gastrointestinal intolerance and bleeding with non-narcotic analgesics. Drugs 32(suppl 4):71- 89, 1986","journal-title":"Drugs"},{"key":"294536_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0140-6736(80)90282-2","volume":"2","author":"JW Hoftiezer","year":"1980","unstructured":"Hoftiezer JW, Silvoso GR, Burks M, Ivey KJ: Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet 2:609 - 612, 1980","journal-title":"Lancet"},{"key":"294536_CR27","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(94)90185-6","volume":"343","author":"MJS Langman","year":"1994","unstructured":"Langman MJS, Well J, Wainwright P, et al: Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 343:1075- 1078, 1994","journal-title":"Lancet"},{"key":"294536_CR28","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1016\/S0021-9258(18)53294-4","volume":"268","author":"EA Meade","year":"1993","unstructured":"Meade EA, Smith WL, Dewitt DL: Differential inhibition of prostaglandin endoperoxide synthase (cyclooxyge nase ) isoenzymes by aspirin and other nonsteroidal anti-inflammatory drugs. J Biol Chem 268:6610 - 6614, 1993","journal-title":"J Biol Chem"},{"key":"294536_CR29","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0022-3565(25)24061-7","volume":"217","author":"P Patrignani","year":"1994","unstructured":"Patrignani P, Panara MR, Greco A, et al: Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther 217:1705- 1712, 1994","journal-title":"J Pharmacol Exp Ther"},{"key":"294536_CR30","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1001\/archinte.153.22.2565","volume":"153","author":"SH Roth","year":"1993","unstructured":"Roth SH, Tindall EA, Jain AK, et al: A controlled study comparing the effects of nabume tone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract. Arch Intern Med 153:2565- 2571, 1993","journal-title":"Arch Intern Med"},{"key":"294536_CR31","first-page":"309","volume":"4","author":"HW Inman","year":"1990","unstructured":"Inman HW, Wilton LV, Pearce GL, Waller PC: Prescription-event monitoring of nabumetone. Pharm Med 4:309 - 317, 1990","journal-title":"Pharm Med"},{"key":"294536_CR32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0016-5085(89)80064-2","volume":"96","author":"DY Graham","year":"1989","unstructured":"Graham DY: Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy. Gastroente rology 96:675- 681, 1989","journal-title":"Gastroente rology"},{"key":"294536_CR33","first-page":"1121","volume":"72","author":"A Robert","year":"1977","unstructured":"Robert A, Nezamis JE, Lancaster C, et al: Gastric cytoprotective property of prostaglandins. Gastroenterology 72:1121, 1977","journal-title":"Gastroenterology"},{"issue":"3","key":"294536_CR34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0016-5085(79)90002-7","volume":"77","author":"A Robert","year":"1979","unstructured":"Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats: Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 77(3):433- 443, 1979","journal-title":"Gastroenterology"},{"key":"294536_CR35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0016-5085(79)90235-X","volume":"77","author":"A Robert","year":"1979","unstructured":"Robert A: Cytoprotection by prostaglandins. Gastroenterology 77:761- 766, 1979","journal-title":"Gastroenterology"},{"key":"294536_CR36","first-page":"25","volume":"2A","author":"WDW Rees","year":"1988","unstructured":"Rees WDW, Shorrock CJ: Overview of gastroduodenal mucosal protection. Am J Med 2A:25- 34, 1988","journal-title":"Am J Med"},{"key":"294536_CR37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","volume":"231","author":"JR Vane","year":"1971","unstructured":"Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (London) New Biol 231:232- 235, 1971","journal-title":"Nature (London) New Biol"},{"key":"294536_CR38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0016-5085(89)80055-1","volume":"96","author":"JS Redfern","year":"1989","unstructured":"Redfern JS, Feldman M: Role of endogenous prostaglandins in preventing gastrointestinal ulceration: Induction of ulcers by antibodies to prostaglandins. Gastroenterology 96:596 - 605, 1989","journal-title":"Gastroenterology"},{"issue":"suppl192","key":"294536_CR39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/00365529209095973","volume":"27","author":"JL Wallace","year":"1992","unstructured":"Wallace JL: Non-steroidal anti-inflammatory gastropathy and cytoprotection: Pathogenesis and mechanisms re-examined. Scand J Gastroenterol 27( suppl 192):3- 8, 1992","journal-title":"Scand J Gastroenterol"},{"key":"294536_CR40","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1073\/pnas.89.16.7384","volume":"89","author":"T Hla","year":"1992","unstructured":"Hla T, Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89:7384 - 7388, 1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"294536_CR41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/367215a0","volume":"367","author":"J Vane","year":"1994","unstructured":"Vane J: Towards a better aspirin. Nature 367:215- 216, 1994","journal-title":"Nature"},{"key":"294536_CR42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00124743-199606000-00005","volume":"2","author":"LS Simon","year":"1996","unstructured":"Simon LS: Nonsteroidal antiinflammatory drugs and their effects: The importance of COX \u201cselectivity.\u201d J Clin Rheumatol 2:135- 140, 1996","journal-title":"J Clin Rheumatol"},{"key":"294536_CR43","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/BF02233268","volume":"12","author":"A Robert","year":"1967","unstructured":"Robert A, Nezamis JE, Phillips JP: Inhibition of gastric secretion by prostaglandins. Am J Dig Dis 12:1073- 1076, 1967","journal-title":"Am J Dig Dis"},{"key":"294536_CR44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/med.2610100202","volume":"10","author":"PW Collins","year":"1990","unstructured":"Collins PW: Misoprostol: Discovery, development, and clinical applications. Med Res Rev 10:149 - 172, 1990","journal-title":"Med Res Rev"},{"key":"294536_CR45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/BF01308407","volume":"30","author":"MM Cohen","year":"1985","unstructured":"Cohen MM, Clark L, Armstrong L, D'souza J: Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man. Dig Dis Sci 30:605- 611, 1985","journal-title":"Dig Dis Sci"},{"issue":"suppl1A","key":"294536_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0002-9343(87)90578-X","volume":"83","author":"JR Ryan","year":"1987","unstructured":"Ryan JR, Vargas R, Clay GA, McMahon FG: Role of misoprostol in reducing aspirin-induced gastrointestinal blood loss in arthritic patients. Am J Med 83( suppl 1A):41- 44, 1987","journal-title":"Am J Med"},{"key":"294536_CR47","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0016-5085(84)90420-7","volume":"86","author":"DA Gilbert","year":"1984","unstructured":"Gilbert DA, Surawicz CM, Silverstein FE, et al: Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15-methyl prostaglandin E2: An endoscopic study. Gastroenterology 86:339 - 345, 1984","journal-title":"Gastroenterology"},{"key":"294536_CR48","doi-asserted-by":"crossref","first-page":"137S","DOI":"10.1007\/BF01309339","volume":"31","author":"FE Silverstein","year":"1986","unstructured":"Silverstein FE, Kimmey MB, Saunders DR, Levine DS: Gastric protection by misoprostol against 1300 mg aspirin: An endoscopic study. Dig Dis Sci 31:137S- 141S, 1986","journal-title":"Dig Dis Sci"},{"issue":"suppl1A","key":"294536_CR49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0002-9343(87)90576-6","volume":"83","author":"FE Silverstein","year":"1987","unstructured":"Silverstein FE, Kimmey MB, Saunders DR, Levine DS: Gastric protection by misoprostol against 1,300 mg of aspirin: An endoscopic dose- response study. Am J Med 83( suppl 1A):32- 36, 1987","journal-title":"Am J Med"},{"key":"294536_CR50","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0016-5085(89)80062-9","volume":"96","author":"GC Jiranek","year":"1989","unstructured":"Jiranek GC, Kimmey MB, Saunders DR, et al: Misoprostol reduces gastroduodenal injury from one week of aspirin: An endoscopic study. Gastroenterology 96:656 - 661, 1989","journal-title":"Gastroenterology"},{"issue":"Maysuppl","key":"294536_CR51","first-page":"95","volume":"00","author":"FL Lanza","year":"1987","unstructured":"Lanza FL: A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects. Br J Clin Pract 00:(May suppl):95- 101, 1987","journal-title":"Br J Clin Pract"},{"key":"294536_CR52","first-page":"633","volume":"84","author":"FL Lanza","year":"1989","unstructured":"Lanza FL, Fakaouhi D, Rubin A, et al: A double-blind, place-bo-controlled comparison of the efficacy and safety of 50, 100, and 200 mcg of misoprostol QID in the prevention of ibuprofeninduced gastric and duodenal mucosal lesions and symptoms. Am J Gastroenterol 84:633- 636, 1989","journal-title":"Am J Gastroenterol"},{"issue":"suppl1A","key":"294536_CR53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(87)90577-8","volume":"83","author":"E Aadland","year":"1987","unstructured":"Aadland E, Fausa O, Vatn M, et al: Protection by misoprostol against naproxen-induced gastric mucosal damage. Am J Med 83( suppl 1A):37- 40, 1987","journal-title":"Am J Med"},{"key":"294536_CR54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-119-4-199308150-00001","volume":"119","author":"DY Graham","year":"1993","unstructured":"Graham DY, White RH, Moreland LW, et al: Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Ann Intern Med 119:257- 262, 1993","journal-title":"Ann Intern Med"},{"key":"294536_CR55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/03009749409103056","volume":"23","author":"SL Elliott","year":"1994","unstructured":"Elliott SL, Yeomans ND, Buchanan RR, Smallwood RA: Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers. A placebo-controlled trial. Scand J Rheumatol 23:171- 176, 1994","journal-title":"Scand J Rheumatol"},{"key":"294536_CR56","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/BF02064210","volume":"40","author":"NM Agrawal","year":"1995","unstructured":"Agrawal NM, Van Kerckhove HE, Erhardt LJ, Geis GS: Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers. A one-year study. Dig Dis Sci 40:1125- 1131, 1995","journal-title":"Dig Dis Sci"},{"key":"294536_CR57","first-page":"A190","volume":"106","author":"AS Taha","year":"1994","unstructured":"Taha AS, Hudson N, Trye P, et al: Prevention of NSAID-related gastric and duodenal ulcers by famotidine. A placebo-controlled double-blind study. Gastroenterology 106:A190, 1994","journal-title":"Gastroenterology"},{"key":"294536_CR58","first-page":"1644","volume":"89","author":"TJ Simon","year":"1994","unstructured":"Simon TJ, Berger ML, Hoover ME, et al: Famotidine for the prevention of gastric and duodenal ulcers associated with non-steroidal antiinflammatory drugs. Am J Gastroenterol 89:1644, 1994 (abstract)","journal-title":"Am J Gastroenterol"},{"issue":"suppl176","key":"294536_CR59","first-page":"13","volume":"25","author":"E Oddsson","year":"1990","unstructured":"Oddsson E, Gudjonsson H, Thjodleifsson B: Protective effect of omeprazole or ranitidine against naproxen-induced damage to the human gastroduodenal mucosa. Scand J Gastroenterol 25( suppl 176):13, 1990 (abstract)","journal-title":"Scand J Gastroenterol"},{"key":"294536_CR60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02090067","volume":"39","author":"JM Scheiman","year":"1994","unstructured":"Scheiman JM, Behler EM, Loeffler KM, Elta GH: Omeprazole ameliorate s aspirin-induced gastroduodenal injury. Dig Dis Sci 39:97- 103, 1994","journal-title":"Dig Dis Sci"},{"key":"294536_CR61","doi-asserted-by":"crossref","first-page":"A87","DOI":"10.1016\/0016-5085(95)23010-6","volume":"108","author":"P Ekstr\u00f6m","year":"1995","unstructured":"Ekstr\u00f6m P, Carling L, Wetterhus S, Wingren PE, Naesdal J, Lamm M: Omeprazole reduces the frequency of gastroduode nal lesions and dyspeptic symptoms during NSAID treatment. Gastroenterology 108:A87, 1995 (abstract)","journal-title":"Gastroenterology"},{"issue":"4","key":"294536_CR62","first-page":"A86","volume":"110","author":"D Cullen","year":"1996","unstructured":"Cullen D, Bardhan KD, Eisner M, et al: Primary gastroduodenal prophylaxis with omeprazole for NSAID users. Gastroenterology 110( 4):A86, 1996","journal-title":"Gastroenterology"},{"issue":"4","key":"294536_CR63","first-page":"A131","volume":"110","author":"CJ Hawkey","year":"1996","unstructured":"Hawkey CJ, Swannell AJ, Eriksson S, et al: Lower frequency of gastroduodenal ulcers and erosions and dyspeptic symptoms in NSAID users during maintenance with omeprazole compared with ranitidine. Gastroenterology 110( 4):A131, 1996","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"294536_CR64","first-page":"A232","volume":"25","author":"ND Yeomans","year":"1996","unstructured":"Yeomans ND, Swannell AJ, Walan A, Lamm M, Naesdal J, Hawkey CJ: Direct comparison of omeprazole and misoprostol as maintenance treatment for NSAID-associated gastroduode nal ulcers, erosions, and symptoms. Rheumatol Eur 25 (Suppl): A232, 1996 (abstract)","journal-title":"Rheumatol Eur"},{"key":"294536_CR65","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF02090209","volume":"39","author":"M Janssen","year":"1994","unstructured":"Janssen M, Dijkmans BA, Vandenbroucke JP, Biemond I, Lamers CB: Achlorhydria does not protect against upper gastrointestinal ulcers during NSAID use. Dig Dis Sci 39:362- 365, 1994","journal-title":"Dig Dis Sci"},{"key":"294536_CR66","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJM199211263272207","volume":"327","author":"RP Walt","year":"1992","unstructured":"Walt RP: Misoprostol for the treatment of peptic ulcer and antiinflammatory drug-induced gastroduodenal ulceration. N Engl J Med 327:1575- 1580, 1992","journal-title":"N Engl J Med"},{"key":"294536_CR67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-123-4-199508150-00001","volume":"123","author":"FE Silverstein","year":"1995","unstructured":"Silverstein FE, Graham DY, Senior JR, et al: Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 123:241- 249, 1995","journal-title":"Ann Intern Med"},{"issue":"suppl28","key":"294536_CR68","first-page":"11","volume":"18","author":"GS Geis","year":"1991","unstructured":"Geis GS, Stead H, Wallemark CB, et al: Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions. J Rheumatol 18( suppl 28):11- 14, 1991","journal-title":"J Rheumatol"},{"key":"294536_CR69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.291.6488.97","volume":"291","author":"Medical Research Council Working Party","year":"1985","unstructured":"Medical Research Council Working Party: MRC trial of treatment of mild hypertension. BMJ 291:97- 104, 1985","journal-title":"BMJ"},{"key":"294536_CR70","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.1984.03340270029025","volume":"251","author":"Lipid Research Clinics Program","year":"1984","unstructured":"Lipid Research Clinics Program: The Lipid Research Clinics coronary primary prevention trial results. JAMA 251:351- 374, 1984","journal-title":"JAMA"},{"issue":"suppl","key":"294536_CR71","first-page":"S185","volume":"39","author":"JU Avorn","year":"1996","unstructured":"Avorn JU, Solomon D, Levin R, Lo J: Epidemiologic analysis of prophylactic drug use and NSAID gastropathy. Arthritis Rheum 39( suppl):S185, 1996 (abstract 827)","journal-title":"Arthritis Rheum"},{"issue":"suppl","key":"294536_CR72","first-page":"S206","volume":"38","author":"LS Simon","year":"1995","unstructured":"Simon LS, Polisson RP, Hatoum HT, Bittman RM: Risk factors for serious nonsteroidal induced GI complications: The risk reduction effect of misoprostol therapy in the individual \u201cat-risk\u201d patient. Arthritis Rheum 38(suppl):S206, 1995","journal-title":"Arthritis Rheum"},{"key":"294536_CR73","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/art.1780360404","volume":"36","author":"SE Gabriel","year":"1993","unstructured":"Gabriel SE, Jaakkimainen RL, Bombardier C: The cost-effectiveness of misoprostol for nonsteroidal anti-inflammatory drug-associated adverse gastrointestinal events. Arthritis Rheum 36:447- 459, 1993","journal-title":"Arthritis Rheum"},{"key":"294536_CR74","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-123-5-199509010-00004","volume":"123","author":"JB Raskin","year":"1995","unstructured":"Raskin JB, White RH, Jackson JE, et al: Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: A comparison of three regimens. Ann Intern Med 123:344 - 350, 1995","journal-title":"Ann Intern Med"},{"key":"294536_CR75","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/ard.52.12.881","volume":"52","author":"JA Melo Gomes","year":"1993","unstructured":"Melo Gomes JA, Roth SH, Zeeh J, Bruyn GAW, Woods EM, Geis GS: Double-blind comparison of efficacy and gastroduodenal safety of diclofenac\/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis. Ann Rheum Dis 52:881- 885, 1993","journal-title":"Ann Rheum Dis"},{"key":"294536_CR76","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/106002809302700517","volume":"27","author":"MD Murray","year":"1993","unstructured":"Murray MD, Birt JA, Manatunga AK, Darnell JC: Medication compliance in elderly outpatients using twice-daily dosing and unit-of-use packaging. Ann Pharmacother 27:616 - 621, 1993","journal-title":"Ann Pharmacother"},{"key":"294536_CR77","first-page":"300","volume":"94","author":"JT Kirchner","year":"1994","unstructured":"Kirchner JT: Nonsteroidal anti-inflammatory drug use in the elderly. J Am Osteopath Assoc 94:300 - 304, 1994","journal-title":"J Am Osteopath Assoc"},{"issue":"suppl1","key":"294536_CR78","first-page":"18","volume":"56","author":"C Salzman","year":"1995","unstructured":"Salzman C: Medication compliance in the elderly. J Clin Psychiatry 56( suppl 1):18 - 22, 1995","journal-title":"J Clin Psychiatry"},{"issue":"suppl96","key":"294536_CR79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/03009749209095094","volume":"21","author":"JR Hannequin","year":"1992","unstructured":"Hannequin JR: Efficacy of Arthrotec in the treatment of rheumatoid arthritis. Scand J Rheumatol 21( suppl 96):7- 14, 1992","journal-title":"Scand J Rheumatol"},{"issue":"suppl96","key":"294536_CR80","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/03009749209095095","volume":"21","author":"M Doherty","year":"1992","unstructured":"Doherty M: The efficacy of Arthrotec in the treatment of osteoarthritis. Scand J Rheumatol 21( suppl 96):15- 21, 1992","journal-title":"Scand J Rheumatol"},{"key":"294536_CR81","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/rheumatology\/31.11.753","volume":"31","author":"W Bolten","year":"1992","unstructured":"Bolten W, Melo Gomes JA, Stead H, Geis GS: The gastroduodenal safety and efficacy of the fixed combination of diclofenac and misoprostol in the treatment of osteoarthritis. Br J Rheumatol 31:753- 758, 1992","journal-title":"Br J Rheumatol"},{"key":"294536_CR82","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03009749209095074","volume":"21","author":"W Verdickt","year":"1992","unstructured":"Verdickt W, Moran C, Hantzschel H, Fraga AM, Stead H, Geis GS: A double-blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis. Scand J Rheumatol 21:85- 91, 1992","journal-title":"Scand J Rheumatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018895417831.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1018895417831\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018895417831.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T03:15:19Z","timestamp":1752462919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1018895417831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["294536"],"URL":"https:\/\/doi.org\/10.1023\/a:1018895417831","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}